Welcome back, degens and diamond-hands, to another edition of the Single-Stock ETF weekly recap, where we dive into the fastest game on the street. The action was fast and furious this past week, with traders making targeted strikes and high-conviction bets on their favorite (and least favorite) names. The space continues to be a magnet for speculative capital, pulling in a cool $572 million in net flows over the last five trading days alone. With total assets under management (AUM) now sitting at a hefty $37.8 billion, it’s clear the appetite for high-octane, single-name exposure is only growing. Let’s break down who won, who lost, and where the money is moving.
Performance: A Tale of Extremes
This week was a stark reminder that in the world of leveraged and inverse ETFs, fortunes are made and lost in the blink of an eye. There was no room for indecision as performance spreads were massive.
- Levered ETFs: The undisputed champion of the week was the T-REX 2X Long SNOW Daily Target ETF (SNOU), which absolutely skyrocketed, posting a staggering +42.35% gain. On the flip side, anyone holding the GraniteShares 2x Long MRVL Daily ETF (MVLL) felt the pain as it cratered -30.13%, taking the title for the week’s biggest loser.
- Inverse ETFs: For the bears who got it right, the T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) delivered a beautiful +13.66% return as MicroStrategy’s stock stumbled. The award for worst timing goes to the shorts on IONQ, as the Defiance Daily Target 2x Short IONQ ETF (IONZ) got steamrolled, dropping -15.12%.
- Synthetic Income ETFs: Proving that you can still generate massive returns from options strategies, the YieldMax SNOW Option Income Strategy ETF (SNOY) surfed the Snowflake wave to a handsome +14.38% gain. Meanwhile, the implosion in Moderna hurt income players, with the YieldMax MRNA Option Income Strategy ETF (MRNY) dropping -9.59%.
- Underlying Movers & Shakers: The primary drivers of this week’s chaos were Snowflake (SNOW), which soared an incredible 21.26%, and Alibaba (BABA), which popped 9.81%. On the downside, Marvell Technology (MRVL) was the week’s biggest punching bag, falling -13.88%, followed closely by Moderna (MRNA), which dropped -11.17%.
Flows: Following the Money (As of 8/28/2025)
Overall, money continued to pour into the single-stock space, with $572 million in net inflows over the last 5 days. Synthetic Income products were the most popular destination for fresh cash, but both Levered and Inverse categories saw net positive flows, showing conviction on both sides of the trade.
Flows by Category
Here’s how the money moved across the major categories:
- Levered ETFs
- AUM: $22.7 Billion
- 5-Day Flow: +$196 Million
- 30-Day Flow: +$248 Million
- YTD Flow: +$4.20 Billion
- Inverse ETFs
- AUM: $1.33 Billion
- 5-Day Flow: +$79 Million
- 30-Day Flow: -$137 Million
- YTD Flow: +$1.26 Billion
- Synthetic Income ETFs
- AUM: $13.78 Billion
- 5-Day Flow: +$311 Million
- 30-Day Flow: +$1.66 Billion
- YTD Flow: +$11.76 Billion
Issuers: The Arms Race
The battle for dominance among issuers is heating up, with firms fighting tooth and nail for trader attention and assets.
- Weekly Winners: GraniteShares had a monster week, absolutely dominating the flow leaderboard by pulling in an enormous $684 million in 5-day inflows.
- Weekly Losers: It was a tougher week for Direxion, which saw the largest 5-day outflows, bleeding $462 million.
- The Titans: The top of the mountain remains crowded. YieldMax continues to hold the AUM crown with $12.7 billion (33.6% market share), but Direxion ($9.4 billion / 24.8%) and GraniteShares ($8.6 billion / 22.6%) are right on their heels, making for a fierce three-way race.
- The Newcomers: The product creation machine is in overdrive, with a stunning 79 new single-stock ETFs launched in just the past 3 months. The most prolific issuer during this blitz was Leverage Shares, which has been aggressively expanding its lineup.
A Word From Our Lawyers
Alright, listen up. This commentary is for informational and entertainment purposes only. It is absolutely not financial advice.
Single-stock ETFs are the financial equivalent of strapping yourself to a rocket. These are high-octane, speculative tools designed for short-term bets. They are wildly unsuitable for long-term investing, your 401(k), or your grandma’s retirement account—unless your grandma is a seasoned degen trader, in which case, respect.
Remember, leverage magnifies gains AND losses. The daily reset feature means that over time, your returns can and will look very different from the underlying stock’s performance. You could get completely wiped out even if you’re eventually right on the direction of the stock. Past performance is no guarantee of future results, and rocket emojis in a Reddit thread do not count as due diligence.
We strongly urge you to do your own research and consult a qualified financial advisor who can talk you through the risks. And let’s be crystal clear: you can lose all of your money, and possibly your shirt, very, very quickly. Trade smart.
